Patents by Inventor Heather Finlay

Heather Finlay has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HETEROCYCLIC CETP INHIBITORS
    Publication number: 20120322761
    Abstract: Compounds of formula Ia and Ib wherein A, B, C and R1 are described herein.
    Type: Application
    Filed: August 29, 2012
    Publication date: December 20, 2012
    Inventors: Mark E. Salvati, Heather Finlay, Bang-Chi Chen, Lalgudi S. Harikrishnan, Ji Jiang, James A. Johnson, Muthoni G. Kamau, R. Michael Lawrence, Jianqing Li, John Lloyd, Michael M. Miller, Zulan Pi, Jennifer X. Qiao, Richard A. Rampulla, Jacques Y. Roberge, Tammy C. Wang, Yufeng Wang, Wu Yang
  • Heterocyclic CETP inhibitors
    Patent number: 8304403
    Abstract: Compounds of formula Ia and Ib and wherein A, B, C and R1 are described herein.
    Type: Grant
    Filed: June 10, 2010
    Date of Patent: November 6, 2012
    Assignee: Bristol-Myers Squibb Company
    Inventors: Mark E. Salvati, Heather Finlay, Bang-Chi Chen, Lalgudi S. Harikrishnan, Ji Jiang, James A. Johnson, Muthoni G. Kamau, R. Michael Lawrence, Jianqing Li, John Lloyd, Michael M. Miller, Zulan Pi, Jennifer X. Qiao, Richard A. Rampulla, Jacques Y. Roberge, Tammy C. Wang, Yufeng Wang, Wu Yang
  • QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS
    Publication number: 20120232068
    Abstract: A compound of formula (I) wherein A, X, Y, Z, R1 and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur associated disorders, and other disorders mediated by ion channel function.
    Type: Application
    Filed: September 1, 2010
    Publication date: September 13, 2012
    Applicant: Briston-Myers Squibb Company
    Inventors: James A. Johnson, John Lloyd, Heather Finlay, Ji Jiang, James Neels, Naveen Kumar Dhondi, Prashantha Gunaga, Abhisek Banerjee
  • ACYCLIC IKUR INHIBITORS
    Publication number: 20120094983
    Abstract: A compound of formula I wherein R1, R2, R3, R4 and R5 are described herein.
    Type: Application
    Filed: March 15, 2011
    Publication date: April 19, 2012
    Inventors: James A. Johnson, Yoon Jeon, John Lloyd, Heather Finlay
  • Acyclic Iinhibitors
    Patent number: 7915410
    Abstract: A compound of formula I wherein R1, R2, R3, R4 and R5 are described herein.
    Type: Grant
    Filed: September 8, 2006
    Date of Patent: March 29, 2011
    Assignee: Bristol-Myers Squibb Company
    Inventors: James A. Johnson, Yoon Jeon, John Lloyd, Heather Finlay
  • Heterocyclic CETP inhibitors
    Patent number: 7888376
    Abstract: Compounds of formula Ia and Ib wherein A, B, C and R1 are described herein.
    Type: Grant
    Filed: November 15, 2006
    Date of Patent: February 15, 2011
    Assignee: Bristol-Myers Squibb Company
    Inventors: Mark E. Salvati, Heather Finlay, Lalgudi S. Harikrishnan, Ji Jiang, James A. Johnson, Muthoni G. Kamau, R. Michael Lawrence, Michael M. Miller, Jennifer X. Qiao, Tammy C. Wang, Yufeng Wang, Wu Yang
  • HETEROCYCLIC CETP INHIBITORS
    Publication number: 20100267669
    Abstract: Compounds of formula Ia and Ib wherein A, B, C and R1 are described herein.
    Type: Application
    Filed: June 10, 2010
    Publication date: October 21, 2010
    Inventors: Mark E. Salvati, Heather Finlay, Bang-Chi Chen, Lalgudi S. Harikrishnan, Ji Jiang, James A. Johnson, Muthoni G. Kamau, R. Michael Lawrence, Jianqing Li, John Lloyd, Michael M. Miller, Zulan Pi, Jennifer X. Qiao, Richard A. Rampulla, Jacques Y. Roberge, Tammy C. Wang, Yufeng Wang, Wu Yang
  • Heterocyclic CETP inhibitors
    Patent number: 7790770
    Abstract: Compounds of formula Ia and Ib wherein A, B, C and R1 are described herein.
    Type: Grant
    Filed: November 13, 2006
    Date of Patent: September 7, 2010
    Assignee: Bristol-Myers Squibb Company
    Inventors: Mark E. Salvati, Heather Finlay, Lalgudi S. Harikrishnan, Ji Jiang, James A. Johnson, Muthoni G. Kamau, R. Michael Lawrence, John Lloyd, Michael M. Miller, Zulan Pi, Jennifer X. Qiao, Richard A. Rampulla, Jacques Y. Roberge, Tammy C. Wang, Yufeng Wang, Wu Yang
  • HETEROCYCLO INHIBITORS OF POTASSIUM CHANNEL FUNCTION
    Publication number: 20090312307
    Abstract: Novel heterocyclo compounds useful as inhibitors of potassium channel function (especially inhibitors of the Kv1 subfamily of voltage gated K+ channels, especially inhibitors Kv1.5 which has been linked to the ultra-rapidly activating delayed rectifier K+ current IKur), methods of using such compounds in the prevention and treatment of arrhythmia and IKur-associated conditions, and pharmaceutical compositions containing such compounds.
    Type: Application
    Filed: August 11, 2009
    Publication date: December 17, 2009
    Inventors: John Lloyd, Yoon T. Jeon, Heather Finlay, Lin Yan, Michael F. Gross, Serge Beaudoin
  • Heterocyclo inhibitors of potassium channel function
    Patent number: 7582654
    Abstract: Novel heterocyclo compounds useful as inhibitors of potassium channel function (especially inhibitors of the Kv1 subfamily of voltage gated K+ channels, especially inhibitors Kv1.5 which has been linked to the ultra-rapidly activating delayed rectifier K+ current IKur), methods of using such compounds in the prevention and treatment of arrhythmia and IKur-associated conditions, and pharmaceutical compositions containing such compounds.
    Type: Grant
    Filed: July 21, 2005
    Date of Patent: September 1, 2009
    Assignees: Bristol-Myers Squibb Company, Icagen, Inc.
    Inventors: John Lloyd, Yoon T. Jeon, Heather Finlay, Lin Yan, Michael F. Gross, Serge Beaudoin
  • Heterocyclic dihydropyrimidine compounds
    Patent number: 7541362
    Abstract: Novel heterocyclic dihydropyrimidine compounds useful as inhibitors of potassium channel function (especially inhibitors of the Kv1 subfamily of voltage gated K+ channels, especially inhibitors Kv1.5 which has been linked to the ultra-rapidly activating delayed rectifier K+ current IKur), methods of using such compounds in the prevention and treatment of arrhythmia and IKur-associated conditions, and pharmaceutical compositions containing such compounds.
    Type: Grant
    Filed: December 6, 2006
    Date of Patent: June 2, 2009
    Assignee: Bristol-Myers Squibb Company
    Inventors: Karnail S. Atwal, Wayne Vaccaro, John Lloyd, Heather Finlay, Lin Yan, Rao S. Bhandaru
  • HETEROCYCLIC CETP INHIBITORS
    Publication number: 20070161685
    Abstract: Compounds of formula Ia and Ib wherein A, B, C and R1 are described herein.
    Type: Application
    Filed: November 15, 2006
    Publication date: July 12, 2007
    Inventors: Mark Salvati, Heather Finlay, Lalgudi Harikrishnan, Ji Jiang, James Johnson, Muthoni Kamau, R. Lawrence, Michael Miller, Jennifer Qiao, Tammy Wang, Yufeng Wang, Wu Yang
  • CYCLOALKYL INHIBITORS OF POTASSIUM CHANNEL FUNCTION
    Publication number: 20070142333
    Abstract: Novel cycloalkyl compounds useful as inhibitors of potassium channel function (especially inhibitors of the Kv1 subfamily of voltage gated K+ channels, especially inhibitors Kv1.5 which has been linked to the ultra-rapidly activating delayed rectifier K+ current IKur), methods of using such compounds in the prevention and treatment of arrhythmia and IKur-associated conditions, and pharmaceutical compositions containing such compounds.
    Type: Application
    Filed: February 2, 2007
    Publication date: June 21, 2007
    Inventors: John Lloyd, Yoon Jeon, Heather Finlay, Lin Yan, Michael Gross, Serge Beaudoin
  • HETEROCYCLIC CETP INHIBITORS
    Publication number: 20070135631
    Abstract: Compounds of formula Ia and Ib wherein A, B, C and R1 are described herein.
    Type: Application
    Filed: November 13, 2006
    Publication date: June 14, 2007
    Inventors: Mark Salvati, Heather Finlay, Bang-Chi Chen, Lalgudi Harikrishnan, Ji Jiang, James Johnson, Muthoni Kamau, R. Lawrence, Jianqing Li, John Lloyd, Michael Miller, Zulan Pi, Jennifer Qiao, Richard Rampulla, Jacques Roberge, Tammy Wang, Yufeng Wang, Wu Yang
  • Heterocyclic dihydropyrimidine compounds
    Publication number: 20070099899
    Abstract: Novel heterocyclic dihydropyrimidine compounds useful as inhibitors of potassium channel function (especially inhibitors of the Kv1 subfamily of voltage gated K+ channels, especially inhibitors Kv1.5 which has been linked to the ultra-rapidly activating delayed rectifier K+ current IKur), methods of using such compounds in the prevention and treatment of arrhythmia and IKur-associated conditions, and pharmaceutical compositions containing such compounds.
    Type: Application
    Filed: December 6, 2006
    Publication date: May 3, 2007
    Inventors: Karnail Atwal, Wayne Vaccaro, John Lloyd, Heather Finlay, Lin Yan, Rao Bhandaru
  • Acyclic Ikur inhibitors
    Publication number: 20070082909
    Abstract: A compound of formula I wherein R1, R2, R3, R4 and R5 are described herein.
    Type: Application
    Filed: September 8, 2006
    Publication date: April 12, 2007
    Inventors: James Johnson, Yoon Jeon, John Lloyd, Heather Finlay
  • Cycloalkyl inhibitors of potassium channel function
    Patent number: 7202253
    Abstract: Novel cycloalkyl compounds useful as inhibitors of potassium channel function (especially inhibitors of the Kv1 subfamily of voltage gated K+ channels, especially inhibitors Kv1.5 which has been linked to the ultra-rapidly activating delayed rectifier K+ current IKur), methods of using such compounds in the prevention and treatment of arrhythmia and IKur-associated conditions, and pharmaceutical compositions containing such compounds.
    Type: Grant
    Filed: November 24, 2004
    Date of Patent: April 10, 2007
    Assignees: Bristol-Myers Squibb Company, Icagen, Inc.
    Inventors: John Lloyd, Yoon T. Jeon, Heather Finlay, Lin Yan, Michael F. Gross, Serge Beaudoin
  • Heterocyclic dihydropyrimidine compounds
    Patent number: 7157451
    Abstract: Novel heterocyclic dihydropyrimidine compounds useful as inhibitors of potassium channel function (especially inhibitors of the Kv1 subfamily of voltage gated K+ channels, especially inhibitors Kv1.5 which has been linked to the ultra-rapidly activating delayed rectifier K+ current IKur), methods of using such compounds in the prevention and treatment of arrhythmia and IKur-associated conditions, and pharmaceutical compositions containing such compounds.
    Type: Grant
    Filed: September 12, 2003
    Date of Patent: January 2, 2007
    Assignee: Bristol-Myers Squibb Company
    Inventors: Karnail S. Atwal, Wayne Vaccaro, John Lloyd, Heather Finlay, Lin Yan, Rao S. Bhandaru
  • Heterocyclo inhibitors of potassium channel function
    Patent number: 7005436
    Abstract: Novel heterocyclo compounds useful as inhibitors of potassium channel function (especially inhibitors of the Kv1 subfamily of voltage gated K+ channels, especially inhibitors Kv1.5 which has been linked to the ultra-rapidly activating delayed rectifier K+ current IKur), methods of using such compounds in the prevention and treatment of arrhythmia and IKur-associated conditions, and pharmaceutical compositions containing such compounds.
    Type: Grant
    Filed: April 16, 2003
    Date of Patent: February 28, 2006
    Assignees: Bristol Myers Squibb Company, Icagen, Inc.
    Inventors: John Lloyd, Yoon T. Jeon, Heather Finlay, Lin Yan, Michael F. Gross, Serge Beaudoin
  • Heterocyclo inhibitors of potassium channel function
    Publication number: 20060014792
    Abstract: Novel heterocyclo compounds useful as inhibitors of potassium channel function (especially inhibitors of the Kv1 subfamily of voltage gated K+ channels, especially inhibitors Kv1.5 which has been linked to the ultra-rapidly activating delayed rectifier K+ current IKur), methods of using such compounds in the prevention and treatment of arrhythmia and IKur-associated conditions, and pharmaceutical compositions containing such compounds.
    Type: Application
    Filed: July 21, 2005
    Publication date: January 19, 2006
    Inventors: John Lloyd, Yoon Jeon, Heather Finlay, Lin Yan, Michael Gross, Serge Beaudoin